MedTrace Logo

Autologous Prefabrication of Body Surface Tissues/ Organs(e.g. Joint)

NCT02595047 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 1

Last updated 2015-11-03

No results posted yet for this study

Summary

The purpose of this study is to observe the feasibility and its application of autologous prefabrication for body surface tissues/oranges

Conditions

  • Soft Tissue Infections
  • Intentional Self Harm by Other Specified Means

Interventions

PROCEDURE

tissue/ organ prefabrication

tissue/ organ is prefabricated in vivo independent of exogenous factors for replacement/ reconstruction purposes

Sponsors & Collaborators

  • Shanghai Jiao Tong University School of Medicine

    lead OTHER

Principal Investigators

  • Qingfeng Li, MD,PhD · Department of Plastic and Reconstructive Surgery, Shanghai 9th People'sHospital

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
5 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2013-01-31
Primary Completion
2015-06-30
Completion
2016-12-31

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02595047 on ClinicalTrials.gov